Priorities for tuberculosis research: A systematic review

The Lancet Infectious Diseases

Volumn 10, Issue 12, 2010, Pages 886-892

  Rylance, Jamie ^a,b   Pai, Madhukar ^c   Lienhardt, Christian ^d   Garner, Paul ^b  

^a MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC RESEARCH; DIAGNOSTIC TEST; DRUG DEVELOPMENT; FUNDING; HEALTH SERVICES RESEARCH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TUBERCULOSIS; TUBERCULOSIS CONTROL; VACCINE PRODUCTION; WORLD HEALTH ORGANIZATION;

HUMANS; MYCOBACTERIUM TUBERCULOSIS; RESEARCH; TUBERCULOSIS;

EID: 78649447046     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70201-2     Document Type: Review

References (46)

1. Global tuberculosis control: a short update to the 2009 report. WHO/HTM/TB/2009426 2009, WHO, World Health Organization, Geneva, (accessed July 1, 2010). http://whqlibdoc.who.int/publications/2009/9789241598866_eng.pdf.
2. Priority setting methodologies in health research April 10-11, 2008, WHO and Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, (accessed July 1, 2010). http://apps.who.int/tdr/stewardship/pdf/Priority_setting_Workshop_Summary10_04_08.pdf.
3. Agarwal N Tuberculosis research and development: a critical analysis of funding trends, 2005-2007 an update March, 2009, Treatment Action Group, New York, (accessed July 1, 2010). http://www.treatmentactiongroup.org/uploadedFiles/About/Publications/TAG_Publications/2009/TAG%20TB%202009%20web-version2.pdf.
4. The global plan to stop TB, 2006-2015 2006, Stop TB Partnership and WHO, Stop TB Partnership and World Health Organization, Geneva, (accessed Aug 28, 2009). http://www.stoptb.org/assets/documents/global/plan/GlobalPlanFinal.pdf.
5. Priority setting for health research: toward a management process for low and middle income countries 2006, Council on Health Research for Development (COHRED), COHRED, (accessed June 17, 2009). http://www.cohred.org/sites/default/files/WP1_PrioritySetting.pdf.
6. Boraschi D, Abebe Alemayehu M, Aseffa A, et al. Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities. PLoS Negl Trop Dis 2008, 2:e255.
7. Churchyard GJ, Scano F, Grant AD, Chaisson RE Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. J Infect Dis 2007, 196:S52-S62.
8. Cobelens FG, Heldal E, Kimerling ME, et al. Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda. PLoS Med 2008, 5:e150.
9. Donald PR, Maher D, Qazi S A research agenda to promote the management of childhood tuberculosis within national tuberculosis programmes. Int J Tuberc Lung Dis 2007, 11:370-380.
10. Ginsberg AM The tuberculosis epidemic. Scientific challenges and opportunities. Public Health Rep 1998, 113:128-136.
11. Ginsberg AM, Spigelman M Challenges in tuberculosis drug research and development. Nat Med 2007, 13:290-294.
12. Graham SM, Gie RP, Schaaf HS, Coulter JB, Espinal MA, Beyers N Childhood tuberculosis: clinical research needs. Int J Tuberc Lung Dis 2004, 8:648-657.
13. Gupta R, Espinal M A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB). Int J Tuberc Lung Dis 2003, 7:410-414.
14. Hill S, Regondi I, Grzemska M, Matiru R Children and tuberculosis medicines: bridging the research gap. Bull World Health Organ 2008, 86:658.
15. Mitnick CD, Castro KG, Harrington M, Sacks LV, Burman W Randomized trials to optimize treatment of multidrug-resistant tuberculosis. PLoS Med 2007, 4:e292.
16. Nunn P, Harries A, Godfrey-Faussett P, Gupta R, Maher D, Raviglione M The research agenda for improving health policy, systems performance, and service delivery for tuberculosis control: a WHO perspective. Bull World Health Organ 2002, 80:471-476.
17. Remme JH, Blas E, Chitsulo L, et al. Strategic emphases for tropical diseases research: a TDR perspective. Trends Parasitol 2002, 18:421-426.
18. Onyebujoh P, Rodriguez W, Mwaba P Priorities in tuberculosis research. Lancet 2006, 367:940-942.
19. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 2007, 7:428-438.
20. International Standards for Tuberculosis Care (ISTC). The Hague: Tuberculosis Coalition for Technical Assistance Tuberculosis Coalition for Technical Assistance, (accessed Aug 28, 2008). http://www.who.int/tb/publications/2006/istc_report.pdf.
21. TB/HIV research priorities in resource-limited settings: report of an expert consultation Feb 14-15, 2005, WHO, WHO, Geneva, (accessed Aug 28, 2008). http://www.who.int/hiv/pub/tb/tbhivresearchpriorities.pdf.
22. Report of the scientific working group meeting on tuberculosis Oct 3-6, 2006, WHO, WHO and The Special Programme for Research and Training in Tropical Diseases, Geneva, (accessed Nov 11, 2008). http://apps.who.int/tdr/publications/tdr-research-publications/swg-report-tuberculosis/pdf/swg_tub.pdf.
23. Perkins MD, Roscigno G, Zumla A Progress towards improved tuberculosis diagnostics for developing countries. Lancet 2006, 367:942-943.
24. Chaisson RE, Harrington M How research can help control tuberculosis. Int J Tuberc Lung Dis 2009, 13:558-568.
25. Hesseling AC, Cotton MF, Marais BJ, et al. BCG and HIV reconsidered: moving the research agenda forward. Vaccine 2007, 25:6565-6568.
26. Burman WJ, Cotton MF, Gibb DM, Walker AS, Vernon AA, Donald PR Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens. PLoS Med 2008, 5:e176.
27. Fauci AS Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases research agenda and recommendations for priority research. J Infect Dis 2008, 197:1493-1498.
28. Treatment of tuberculosis guidelines 2009, WHO, World Health Organization, Geneva, (accessed June 11, 2010). http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf, 4th edn.
29. Fears R, Kaufmann S, Ter Meulen V, Zumla A Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. Tuberculosis 2010, 90:182-187. EASAC Working Group.
30. Lang H, Quaglio G, Olesen OF Tuberculosis research in the European union: past achievements and future challenges. Tuberculosis 2010, 90:1-6.
31. Harandi AM, Medaglini D, Shattock RJ Vaccine adjuvants: a priority for vaccine research. Vaccine 2010, 28:2363-2366.
32. Harries AD, Murray MB, Jeon CY, et al. Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Trop Med Int Health 2010, 15:659-663.
33. Swaminathan S, Rekha B Pediatric tuberculosis: global overview and challenges. Clin Infect Dis 2010, 50(suppl 3):S184-S194.
34. Chamie G, Luetkemeyer A, Charlebois E, Havlir DV Tuberculosis as part of the natural history of HIV infection in developing countries. Clin Infect Dis 2010, 50(suppl 3):S245-S254.
35. Lienhardt C, Davies G Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities. Int J Tuberc Lung Dis 2010, 14:528-537.
36. Pai M, Minion J, Steingart K, Ramsay A New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 2010, 16:271-284.
37. Ma Z, Lienhardt C, McIlleron H, Nunn AJ, Wang X Global tuberculosis drug development pipeline: the need and the reality. Lancet 2010, 375:2100-2109.
38. Marais BJ, Raviglione MC, Donald PR, et al. Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet 2010, 375:2179-2191.
39. Dye C, Williams BG Eliminating human tuberculosis in the twenty-first century. J R Soc Interface 2008, 5:653-662.
40. Dowdy DW, Chaisson RE The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection. Bull World Health Organ 2009, 87:296-304.
41. Stop TB TB impact measurement: policy and recommendations for how to assess the epidemiological burden of TB and the impact of TB control 2009, WHO, World Health Organization, Geneva.
42. Lavis JN How can we support the use of systematic reviews in policymaking?. PLoS Med 2009, 6:e1000141.
43. Stewart R, Oliver S A systematic map of studies of patients' and clinicians' research priorities 2008, James Lind Alliance, London, (accessed June 29, 2010). http://www.lindalliance.org/pdfs/JLA%20Internal%20Reports/090712_JLAreport_RS_map_studies_PPI%20&%20Clinicians_research%20priorities_with%20appendices.pdf.
44. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926.
45. Normand C Ten popular health economic fallacies. J Public Health Med 1998, 20:129-132.
46. Rudan I, El Arifeen S, Black RE, Campbell H Childhood pneumonia and diarrhoea: setting our priorities right. Lancet Infect Dis 2007, 7:56-61.